Home NDC 55289-433-30 Topamax
Product NDC 55289-433
Requested package NDC 55289-433-30
11-digit product format 552890433
Labeler code 55289
Product ID 55289-433_d9f5fa7c-4ccd-0be8-e053-2a95a90ab074
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name topiramate
Dosage form TABLET, COATED
Route ORAL
Labeler PD-Rx Pharmaceuticals, Inc.
Application NDA020505
Marketing category NDA
Marketing start 1997-01-01
Marketing end 0000-00-00
Substance TOPIRAMATE
Active strength 50 mg/1
Pharmacologic classes Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 6 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020505-001 TOPAMAX TOPIRAMATE 100MG TABLET / ORAL AB RLD, RS 1996-12-24 N020505-002 TOPAMAX TOPIRAMATE 200MG TABLET / ORAL AB RLD 1996-12-24 N020505-003 TOPAMAX TOPIRAMATE 300MG TABLET / ORAL 1996-12-24 N020505-004 TOPAMAX TOPIRAMATE 25MG TABLET / ORAL AB RLD 1996-12-24 N020505-005 TOPAMAX TOPIRAMATE 50MG TABLET / ORAL AB RLD 1996-12-24 N020505-006 TOPAMAX TOPIRAMATE 400MG TABLET / ORAL 1996-12-24
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 7 · 246 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N020505-001 TOPAMAX 100MG TABLET / ORAL AB RLD, RS 1996-12-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020505-002 TOPAMAX 200MG TABLET / ORAL AB RLD 1996-12-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020505-003 TOPAMAX 300MG TABLET / ORAL 1996-12-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020505-004 TOPAMAX 25MG TABLET / ORAL AB RLD 1996-12-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020505-005 TOPAMAX 50MG TABLET / ORAL AB RLD 1996-12-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020505-006 TOPAMAX 400MG TABLET / ORAL 1996-12-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020505-001 TOPAMAX 100MG TABLET / ORAL AB RLD, RS 1996-12-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020505-002 TOPAMAX 200MG TABLET / ORAL AB RLD 1996-12-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020505-003 TOPAMAX 300MG TABLET / ORAL 1996-12-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020505-004 TOPAMAX 25MG TABLET / ORAL AB RLD 1996-12-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020505-005 TOPAMAX 50MG TABLET / ORAL AB RLD 1996-12-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020505-006 TOPAMAX 400MG TABLET / ORAL 1996-12-24 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020505-001 TOPAMAX 100MG TABLET / ORAL AB RLD, RS 1996-12-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020505-002 TOPAMAX 200MG TABLET / ORAL AB RLD 1996-12-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020505-003 TOPAMAX 300MG TABLET / ORAL 1996-12-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020505-004 TOPAMAX 25MG TABLET / ORAL AB RLD 1996-12-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020505-005 TOPAMAX 50MG TABLET / ORAL AB RLD 1996-12-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020505-006 TOPAMAX 400MG TABLET / ORAL 1996-12-24 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020505-001 TOPAMAX 100MG TABLET / ORAL AB RLD, RS 1996-12-24 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020505-002 TOPAMAX 200MG TABLET / ORAL AB RLD 1996-12-24 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020505-003 TOPAMAX 300MG TABLET / ORAL 1996-12-24 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020505-004 TOPAMAX 25MG TABLET / ORAL AB RLD 1996-12-24 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020505-005 TOPAMAX 50MG TABLET / ORAL AB RLD 1996-12-24 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020505-006 TOPAMAX 400MG TABLET / ORAL 1996-12-24 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020505-001 TOPAMAX 100MG TABLET / ORAL AB RLD, RS 1996-12-24 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020505-002 TOPAMAX 200MG TABLET / ORAL AB RLD 1996-12-24 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020505-003 TOPAMAX 300MG TABLET / ORAL 1996-12-24 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020505-004 TOPAMAX 25MG TABLET / ORAL AB RLD 1996-12-24 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020505-005 TOPAMAX 50MG TABLET / ORAL AB RLD 1996-12-24 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020505-006 TOPAMAX 400MG TABLET / ORAL 1996-12-24 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020505-001 TOPAMAX 100MG TABLET / ORAL AB RLD, RS 1996-12-24 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020505-002 TOPAMAX 200MG TABLET / ORAL AB RLD 1996-12-24 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020505-003 TOPAMAX 300MG TABLET / ORAL 1996-12-24 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020505-004 TOPAMAX 25MG TABLET / ORAL AB RLD 1996-12-24 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020505-005 TOPAMAX 50MG TABLET / ORAL AB RLD 1996-12-24 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020505-006 TOPAMAX 400MG TABLET / ORAL 1996-12-24 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020505-001 TOPAMAX 100MG TABLET / ORAL AB RLD, RS 1996-12-24 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020505-002 TOPAMAX 200MG TABLET / ORAL AB RLD 1996-12-24 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020505-003 TOPAMAX 300MG TABLET / ORAL 1996-12-24 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020505-004 TOPAMAX 25MG TABLET / ORAL AB RLD 1996-12-24 2680178bc6a6…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 164 observed states.
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded topiramate ACTIVE INGREDIENT 0H73WJJ391 TOPAMAX (TOPIRAMATE) TABLET, COATED [PD-RX PHARMACEUTICALS, INC.] 7 topiramate ACTIVE MOIETY 0H73WJJ391 TOPAMAX (TOPIRAMATE) TABLET, COATED [PD-RX PHARMACEUTICALS, INC.] 7 carnauba wax INACTIVE INGREDIENT R12CBM0EIZ TOPAMAX (TOPIRAMATE) TABLET, COATED [PD-RX PHARMACEUTICALS, INC.] 7 cellulose, microcrystalline INACTIVE INGREDIENT OP1R32D61U TOPAMAX (TOPIRAMATE) TABLET, COATED [PD-RX PHARMACEUTICALS, INC.] 7 hypromelloses INACTIVE INGREDIENT 3NXW29V3WO TOPAMAX (TOPIRAMATE) TABLET, COATED [PD-RX PHARMACEUTICALS, INC.] 7 lactose monohydrate INACTIVE INGREDIENT EWQ57Q8I5X TOPAMAX (TOPIRAMATE) TABLET, COATED [PD-RX PHARMACEUTICALS, INC.] 7 magnesium stearate INACTIVE INGREDIENT 70097M6I30 TOPAMAX (TOPIRAMATE) TABLET, COATED [PD-RX PHARMACEUTICALS, INC.] 7 polyethylene glycols INACTIVE INGREDIENT 3WJQ0SDW1A TOPAMAX (TOPIRAMATE) TABLET, COATED [PD-RX PHARMACEUTICALS, INC.] 7 polysorbate 80 INACTIVE INGREDIENT 6OZP39ZG8H TOPAMAX (TOPIRAMATE) TABLET, COATED [PD-RX PHARMACEUTICALS, INC.] 7 sodium starch glycolate type A potato INACTIVE INGREDIENT 5856J3G2A2 TOPAMAX (TOPIRAMATE) TABLET, COATED [PD-RX PHARMACEUTICALS, INC.] 7 titanium dioxide INACTIVE INGREDIENT 15FIX9V2JP TOPAMAX (TOPIRAMATE) TABLET, COATED [PD-RX PHARMACEUTICALS, INC.] 7 water INACTIVE INGREDIENT 059QF0KO0R TOPAMAX (TOPIRAMATE) TABLET, COATED [PD-RX PHARMACEUTICALS, INC.] 7
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Topamax TOPIRAMATE Janssen Pharmaceuticals, Inc. 21628112-0c47-11df-95b3-498d55d89593 2026-03-12 Warnings, Adverse reactions Exact identifier application applno (NDA): 020505 application number: NDA020505
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 55289-433-30 55289043330 30 TABLET, COATED in 1 BOTTLE, PLASTIC (55289-433-30) 2012-01-18 0000-00-00 No No Current